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Summary Points
• Worldwide, 8.5 million infants aged less than 6 months (<6m) are acutely malnour-
ished. For the first time, 2013 WHOMalnutrition Guidelines describe their treatment,
but on the basis of “very low quality” evidence, per WHO. More and better research is
urgently needed.
• To prioritise the many possible research questions on infant<6m malnutrition, we used
the systematic, transparent, well-established Child Health and Nutrition Research Initia-
tive (CHNRI) approach. Sixty-four experts scored 60 research questions on the basis of
their answerability, likelihood of intervention efficacy, effectiveness, deliverability, sus-
tainability, impact on disease burden, and impact on equity.
• “How should infant<6m SAM be defined?” was the top-scoring research question; that
this and other basic questions are still needed highlights paucity of evidence on this
topic.
• Other leading questions reflect interest in public health/community-focused models of
care, e.g., “What are priority components of a package of outpatient care?” These ques-
tions are important to inform new outpatient strategies now recommended by WHO.
• Most of our questions received high-priority scores reflecting a great need for a wide vari-
ety of evidence. Several major global initiatives such as the “Scaling Up Nutrition Move-
ment” and “Generation Nutrition” would benefit from better evidence. Our results show
clear ways forward for future research investments.
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Background
Undernutrition is responsible for some 3.1 million child deaths per year, 45% of all deaths
among children aged<5 years [1]. Infants are most at risk [2,3]. Acute malnutrition (compris-
ing wasting, as defined by low weight-for-length; and/or low mid-upper arm circumference;
and/or oedematous malnutrition, Kwashiorkor) is particularly important because of its high
case fatality rate [4,5].
In the last decade, the management of acute malnutrition has been revolutionized by a new
public health-orientated approach to treatment, “Community-based Management of Acute
Malnutrition” (CMAM) [6]. To achieve impact, CMAM focuses on: high programme coverage;
treatment of “uncomplicated” cases on an outpatient basis; the use of nutrient-dense “ready-
to-use therapeutic food” [7]. Programmes are targeted at children aged 6 to 59 months. Con-
trasting this success, the management of acute malnutrition in infants under six months old
(<6m) is often neglected in practice even if described in clinical protocols [8]. When it is de-
scribed, guidelines focus on inpatient-based care alone [9]. Yet, recent estimates suggest that an
estimated 3.8 million infants<6m have severe acute malnutrition (SAM) [10]. This is a mini-
mum estimate since it does not include oedematous SAM. A further 4.7 million infants are esti-
mated to have moderate acute malnutrition (MAM) [10].
Recently updated (December 2013) World Health Organization (WHO) guidelines on the
“Management of Severe Acute Malnutrition in Infants and Children” for the first time have a
chapter devoted to infants<6m [11]. Other key firsts in these guidelines are: distinguishing be-
tween “complicated” (i.e., clinically sick) and “uncomplicated” (i.e., malnourished but clinically
stable and able to eat) cases of infant<6m SAM; outlining outpatient as well as inpatient-
based treatment options [11]. This represents significant progress. However, whilst many of
the WHO recommendations on infants<6m are “strong” [12], the quality of evidence underly-
ing them is “very low” [11,12]. The need for research is widely recognised [11,13,14]. Given
that many research options (questions) are possible and that undertaking any of them requires
significant investment of time and resources, it is vital to concentrate on the most important
questions. A research prioritisation exercise focused on infants<6m is especially timely, rele-
vant, and useful because:
• Nutrition plays a key role in the 2015 Millennium Development Goals (MDGs) [15] and will
continue to matter beyond 2015 [16,17].
• In May 2014, a multi-agency global campaign, “Generation Nutrition” was launched. Its ulti-
mate aim is to “End child deaths from acute malnutrition” [18].
• In November 2014, the first ever “Global Nutrition Report” highlighted a lack of progress
on ending child wasting. It also noted the need to improve coverage of SAM treatment ser-
vices [17].
• The “Scaling Up Nutrition” (SUN) Movement is a rapidly expanding global movement with
54 countries currently signed up [16]. It focuses on the first 1,000 days of life as a critical win-
dow of opportunity to improve nutrition; malnourished infants<6m fall within the move-
ment’s scope.
We used the well-established Child Health and Nutrition Research Initiative (CHRNI) meth-
odology [19] to consult key stakeholders on a range of research questions in order to identify
the most important. We intend this data to be useful in informing the research agenda of gov-
ernments, researchers, investors, international organisations, and national agencies about what
is likely to result in high-impact policies and practices in the management of acute malnutri-
tion in infants<6m (MAMI) in resource-poor settings.
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Methods
CHNRI methodology is described in detail elsewhere: on the website (http://www.chnri.org/
index.php), in a methods paper [19], and in other papers using CHNRI to explore other key
areas of global health [20–24]. It represents an important improvement on traditional re-
search-priority—setting methods, such as literature searches to find gaps in research or com-
paring the burden of disease and estimating economic “payback,” because it is systematic and
transparent about the range of possible research questions and how their final ranks have been
derived. Full protocols are described in S1 Text. In brief:
We began by defining the context and criteria for priority setting. Working as a “core
group” of authors of this paper, we developed a long list of possible research questions based
on previous publications [8], meetings and discussions. By careful phrasing and consolidation
of overlapping ideas, we edited and refined these to a manageable final list of 60 questions di-
vided into three categories: (1) basic epidemiological research, (2) health policy and systems re-
search, and (3) technical questions and interventions. Based on CHNRI’s conceptual
framework, we also agreed on seven judging criteria (Table 1).
As with other CHNRIs, it was up to individual respondents to interpret and imagine what
future interventions might be and how they might meet or not meet the various criteria. We
did not apply weights to these judging criteria (as some CHNRI projects have done) because in-
fant<6m malnutrition is a new and focused area of research and we felt that un-weighted esti-
mates would be clearer and more interpretable by our intended policy audience. Should
readers using our data wish for any reason (e.g., to reflect context-specific priorities) to weight
certain areas more than others, this is possible using the results spreadsheet in S1 Table and re-
ferring to CHNRI methods [19].
We distributed the list of questions and scoring criteria as an online survey to a total of 150
technical experts, experienced practitioners, and policy makers in the field of nutrition and
child health (MAMI “reference group”). These were identified from participation at meetings
and symposia related to nutrition and/or infant and young child feeding and represented a
Table 1. CHNRI judging criteria for each research question (option).
CHNRI Criterion How participants were asked to assess the criterion
Answerability Would you say that a study to answer this research question is possible (e.g.,
feasible, ethically possible, well deﬁned endpoints/outcomes)?
Efﬁcacy Would the intervention(s) arising from the proposed research be efﬁcacious (i.e.,
under research/optimally resourced conditions)?
Effectiveness Would the intervention(s) arising from the proposed research likely be effective
(i.e., under routine programme conditions)?
Deliverability Would the intervention arising from the research be deliverable (taking into
account, for example, design, standardization, safety, health system
infrastructure, human resources, and role of attitudes and demand)?
Sustainability Would the interventions arising from the research be sustainable (taking into
account, for example, ﬁnancial affordability, adequacy of regulation, monitoring
and enforcement, partnership and coordination between civil society and
external donor agencies, and favourable political climate)?
Disease Burden
Reduction
Would you say that interventions arising from the research would eventually
(assuming high deliverability, affordability and sustainability) contribute to a
signiﬁcant reduction in infant malnutrition or mortality or morbidity?
Equity Would you say that interventions arising from the research have potential to
improve equity in disease burden distribution (i.e., could help all segments of the
society, not just the privileged ones)?
doi:10.1371/journal.pmed.1001812.t001
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breadth and depth of expertise, as well as a wide spectrum of stakeholder organisations. An
open invitation to participate was also posted on internet-based technical discussion forums.
Respondents applied each of the seven judging criteria to each of the 60 questions listed by a
“Yes” (1 point), “No” (0 points), “Undecided” (0.5 points), or “Insufficiently informed” (miss-
ing input). Based on these responses, a research priority score (RPS) for each criterion and an
overall RPS were calculated. These could range between 0% (lowest possible RPS) and 100%
(highest possible RPS). The final list of priorities with criterion-specific and overall priority
scores for all 60 research options is presented in S1 Table.
As well as the overall RPS given to various research options, we also assessed the level of
agreement between scorers through the “average expert agreement” (AEA). This could range
between 1 (perfect agreement between all respondents) and 0 (no agreement) [19].
Ethics
As is standard for CHNRI projects, formal ethics review was not needed since the work does
not involve any personal or otherwise sensitive data and deals with professional participants
rather than patients, all solicited via established professional networks. Participants were aware
that their responses would be used for research and publication. Those who completed the
questionnaire were asked whether they were happy to be named as part of the group author
list, and only those answering “yes” are listed. Individual answers to the questions are not pre-
sented and so were anonymous.
Respondents
Sixty-four individuals participated in the survey (Table 2). They comprise the MAMIWorking
Group collaborating authors. Nine out of the 14 original MAMI group took part. Seven others
took part anonymously. This represents a 42.6% response rate for directly invited participants.
Sixty-four percent of respondents were invited directly and the rest came through posts on
technical forums or word of mouth through invitees. Thirty-four respondents completed part
1 only, 20 completed part 2 only, and ten completed both parts.
Research Priorities
S1 Table provides the full list of questions and their scores in excel format. Table 3 shows the
15 research questions that achieved the highest overall research priority score (RPS). These
achieved high scores across all of the judging criteria.
It is revealing of the current state of research around infant<6m SAM that many of the top
questions are very basic. Most striking was the number-one question: “How should infant<6m
Table 2. Profile of respondents (n = 64).
Main employer (n) Main type of work (n) Rural or Urban (n) Mainly based in (n)
Non-governmental organisation (NGO) (27) Operational / programme (35) Both (42) Europe (31)
Academic Institution (16) Academic (19) Rural only (16) North America (13)
United Nations (UN) agency (8) Policy (4) Urban only (6) Eastern Africa (9)
Government Institution (6) Other (6) South Asia (4)
Independent (7) Southern Africa (3)
West Africa (2)
Central America / Caribbean (1)
Australasia (1)
doi:10.1371/journal.pmed.1001812.t002
PLOSMedicine | DOI:10.1371/journal.pmed.1001812 April 21, 2015 4 / 14
T
ab
le
3.
T
h
e
15
re
se
ar
ch
o
p
tio
n
s
th
at
ac
h
ie
ve
d
th
e
h
ig
h
es
to
ve
ra
ll
re
se
ar
ch
p
ri
o
ri
ty
sc
o
re
(%
)w
it
h
av
er
ag
e
ex
p
er
ta
g
re
em
en
t(
ra
n
g
e
0–
1)
.
R
es
ea
rc
h
o
p
tio
n
(q
u
es
ti
o
n
)
Q
u
es
ti
o
n
n
u
m
b
er
R
an
k
A
n
sw
er
ab
ili
ty
E
fﬁ
ca
cy
E
ff
ec
ti
ve
n
es
s
D
el
iv
er
ab
ili
ty
S
u
st
ai
n
ab
ili
ty
D
is
ea
se
b
u
rd
en
re
d
u
ct
io
n
E
q
u
ity
R
P
S
A
E
A
H
ow
sh
ou
ld
in
fa
nt
<
6m
S
A
M
be
de
ﬁ
ne
d?
1
1
94
.3
89
.5
94
.1
98
.3
89
.7
90
.4
91
.7
92
.6
0.
89
W
ha
ta
re
/is
th
e
ke
y
op
po
rt
un
iti
es
/
tim
in
g
w
he
n
in
fa
nt
S
A
M
m
an
ag
em
en
t
ca
n
be
in
co
rp
or
at
ed
w
ith
ot
he
r
he
al
th
ca
re
pr
og
ra
m
m
es
?
26
2
98
.8
90
.5
85
.9
93
.1
90
.4
92
.0
84
.8
90
.8
0.
79
W
ha
ta
re
th
e
pr
io
rit
y
co
m
po
ne
nt
s
of
a
pa
ck
ag
e
of
ca
re
fo
r
ou
tp
at
ie
nt
tr
ea
tm
en
to
fi
nf
an
t<
6m
S
A
M
?
50
3
85
.9
92
.6
95
.0
94
.8
89
.3
94
.0
83
.3
90
.7
0.
68
H
av
in
g
de
te
ct
ed
S
A
M
in
th
e
co
m
m
un
ity
,w
ha
ti
s
th
e
ef
ﬁ
ca
cy
of
pr
ov
id
in
g
ta
rg
et
ed
sk
ill
ed
br
ea
st
fe
ed
in
g
su
pp
or
tt
o
ca
re
gi
ve
rs
of
st
ab
le
in
fa
nt
s?
48
4
86
.9
95
.6
88
.7
87
.9
87
.5
98
.0
88
.0
90
.4
0.
57
H
ow
ca
n
ex
is
tin
g
to
ol
s
be
ad
ap
te
d
an
d/
or
lin
ke
d
to
ge
th
er
to
be
tte
r
id
en
tif
y
an
d
m
an
ag
e
in
fa
nt
<
6m
S
A
M
?
29
5
91
.7
88
.9
87
.9
91
.1
96
.2
94
.2
81
.3
90
.2
0.
80
W
ha
ta
re
th
e
m
os
tf
ea
si
bl
e
to
ol
s
an
d
te
ch
ni
qu
es
fo
r
as
se
ss
in
g
tr
ea
tm
en
t
pr
og
ra
m
m
e
co
ve
ra
ge
fo
r
in
fa
nt
<
6m
S
A
M
?
14
6
89
.5
86
.1
88
.2
10
0.
0
92
.6
84
.6
82
.0
89
.0
0.
59
W
ha
ti
s
th
e
fe
as
ib
ili
ty
,e
ffe
ct
iv
en
es
s,
co
st
-e
ffe
ct
iv
en
es
s
an
d
im
pa
ct
of
di
ffe
re
nt
ap
pr
oa
ch
es
to
pr
om
ot
e
ea
rly
in
iti
at
io
n
an
d
ex
cl
us
iv
ity
of
br
ea
st
fe
ed
in
g?
58
7
91
.3
95
.6
86
.4
91
.4
88
.9
86
.0
83
.3
89
.0
0.
78
W
ha
ta
re
th
e
m
ai
n
ba
rr
ie
rs
to
ex
is
tin
g
in
pa
tie
nt
in
te
rv
en
tio
ns
fo
r
in
fa
nt
<
6m
S
A
M
an
d
ho
w
m
ig
ht
th
ey
be
be
st
ad
dr
es
se
d?
18
8
93
.9
93
.1
92
.2
87
.9
83
.9
80
.0
89
.6
88
.7
0.
72
W
ha
ti
s
th
e
ef
fe
ct
iv
en
es
s,
co
st
,a
nd
sa
fe
ty
of
an
ou
tp
at
ie
nt
-f
oc
us
ed
tr
ea
tm
en
tm
od
el
fo
r
in
fa
nt
s
w
ith
S
A
M
?
21
9
89
.2
84
.3
93
.3
84
.5
78
.8
93
.8
89
.6
87
.6
0.
69
W
hi
ch
su
pe
rv
is
io
n
to
ol
s
an
d
ap
pr
oa
ch
es
ar
e
m
os
te
ffe
ct
iv
e
to
w
ar
ds
im
pr
ov
in
g
th
e
fr
on
t-
lin
e
ca
se
m
an
ag
em
en
to
fi
nf
an
t<
6m
S
A
M
?
27
10
95
.0
86
.8
89
.7
91
.4
89
.3
84
.0
77
.1
87
.6
0.
70
H
ow
ca
n
ex
is
tin
g
ch
ild
he
al
th
an
d
nu
tr
iti
on
re
po
rt
in
g
sy
st
em
s
be
ad
ap
te
d
to
ca
pt
ur
e,
m
on
ito
r
an
d
au
di
td
at
a
on
in
fa
nt
<
6m
S
A
M
?
28
11
92
.7
91
.4
80
.0
96
.6
92
.3
83
.3
76
.1
87
.5
0.
73
W
ha
tr
ol
e
do
C
M
A
M
pr
og
ra
m
m
es
ha
ve
in
de
liv
er
in
g
ou
tp
at
ie
nt
-b
as
ed
tr
ea
tm
en
tf
or
in
fa
nt
<
6m
S
A
M
?
22
12
90
.8
86
.4
89
.7
78
.6
82
.7
93
.8
89
.6
87
.3
0.
71
(C
on
tin
ue
d
)
PLOSMedicine | DOI:10.1371/journal.pmed.1001812 April 21, 2015 5 / 14
T
ab
le
3.
(C
on
tin
ue
d
)
R
es
ea
rc
h
o
p
tio
n
(q
u
es
ti
o
n
)
Q
u
es
ti
o
n
n
u
m
b
er
R
an
k
A
n
sw
er
ab
ili
ty
E
fﬁ
ca
cy
E
ff
ec
ti
ve
n
es
s
D
el
iv
er
ab
ili
ty
S
u
st
ai
n
ab
ili
ty
D
is
ea
se
b
u
rd
en
re
d
u
ct
io
n
E
q
u
ity
R
P
S
A
E
A
H
ow
do
es
br
ea
st
fe
ed
in
g
st
at
us
an
d/
or
ch
an
ge
in
br
ea
st
fe
ed
in
g
st
at
us
im
pa
ct
on
in
fa
nt
<
6m
S
A
M
?
5
13
93
.2
90
.5
90
.9
91
.4
82
.1
88
.5
74
.0
87
.2
0.
79
W
ha
ti
s
th
e
co
ve
ra
ge
of
ex
is
tin
g
tr
ea
tm
en
tp
ro
gr
am
m
es
fo
r
in
fa
nt
<
6m
S
A
M
?
13
14
89
.3
78
.6
84
.4
84
.5
90
.4
81
.3
93
.8
86
.0
0.
84
H
ow
ca
n
ex
is
tin
g
su
rv
ey
s
of
di
ffe
rin
g
de
si
gn
s
an
d
at
di
ffe
re
nt
le
ve
ls
be
ad
ap
te
d
to
in
cl
ud
e
in
fa
nt
s
<
6m
?
7
15
90
.0
90
.9
81
.7
83
.9
86
.5
73
.9
90
.5
85
.3
0.
71
do
i:1
0.
13
71
/jo
ur
na
l.p
m
ed
.1
00
18
12
.t0
03
PLOSMedicine | DOI:10.1371/journal.pmed.1001812 April 21, 2015 6 / 14
SAM be defined?”Until we know how to define a problem, efforts to address it are likely to be
seriously impaired. This lack of consensus on a case definition is a fundamental block in moving
forward. It reflects distinguishing characteristics between infants<6m and older children re-
garding assessment: anthropometric measurement is more challenging [25]; some anthropomet-
ric indicators are not available (e.g., WHO weight-for-length standards do not exist for length
<45 cm); clinical and feeding history matter more in infants than in older children yet can be
difficult to assess. Though there is evidence that it could be successfully used [26, 27], mid-upper
arm circumference (MUAC) measurement is not currently considered suitable for infants<6m.
MUAC has been key for the treatment of acutely malnourished children over 6 months old since
it enables detection in the community and high treatment programme coverage [28].
Other leading questions reflect an interest in public health/community approaches to
infant<6m SAMmanagement, for example, the questions ranked third, “What are the priority
components of a package of care for outpatient treatment of infant<6m SAM?”; fourth, “Hav-
ing detected SAM in the community, what is the efficacy of providing targeted skilled breast-
feeding support to caregivers of stable infants?”; ninth, “What is the effectiveness, cost, and
safety of an outpatient-focused treatment model for infants with SAM?”; and twelfth, “What
role do CMAM programmes have in delivering outpatient-based treatment for infant<6m
SAM?”. These rankings align well with the newWHO policy to distinguish between “compli-
cated” and “uncomplicated” infant<6m SAM. Once classified in this way, outpatient treat-
ment options are made possible for uncomplicated cases: details of these are vague in the
WHO guidelines [11], so it is helpful that our CHNRI has given options. Outpatient care is a
significant shift away from previous guidelines, which implied that all infants<6m automati-
cally need admission [9].
The Average Expert Agreement (AEA) for the top 15 questions was overall high, indicating
good agreement between the different expert respondents. The highest scoring research option
also received the highest AEA score (0.89), indicating the strongest agreement about the im-
portance of this particular research question. High overall AEA also reflects the paucity of cur-
rent evidence around infant<6m SAM. Other CHNRIs have a wider distribution of RPS. With
the exception of the bottom six research questions, all those we put out had an overall RPS of
70% and above. This means that our experts saw them as all being important; since infant
<6m SAM has been a previously neglected area of research, much is still unknown.
Two questions stood out as having low AEA: “What is the efficacy of providing targeted
skilled breastfeeding support to caregivers of stable infants<6m?” and “What are the most fea-
sible tools and techniques for assessing treatment programme coverage for infant<6m SAM?”
This implies a lack of consensus about the importance of these questions.
Table 4 shows the same 15 research questions that achieved the highest overall RPS sorted
by research category. There was a fairly even spread covering basic epidemiology, health poli-
cies, and systems and technical interventions. This illustrated that there are multiple MAMI re-
search priorities across a variety of areas that are not mutually exclusive. It also suggests that
the CHNRI method was able to compare and discriminate among research questions from dif-
ferent areas and that there was no systematic bias against questions from any of the three
research areas.
Table 5 shows the ten research questions that achieved the lowest overall RPS (relative to
the other questions). The absolute score for many of these questions was still high. Many of
these deal with issues pertaining to a subgroup of malnourished infants<6m, e.g., orphans, in-
fants with disabilities, infants with lactose intolerance and those requiring artificial feeding
and/or possible early introduction of complementary feeds. These questions tended to score
low on deliverability, effectiveness, and disease burden reduction. Though the bottom ques-
tions may not have the greatest overall impact, it does not mean that they are not worth
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investing in. They are perhaps appropriate for more specialist organisations and funders with
more focused interests and priorities.
Limitations
We acknowledge our study weaknesses. CHNRI attempts to simplify a highly complex process
of priority setting, gathering together the opinions of a group of experts to bring coherence and
direction to a neglected research area. Some bias is inevitable in the selection of research ques-
tions. A longer list of initial questions had to be condensed down to make the survey accessible
for as many experts as possible. This was achieved by rephrasing to avoid duplication and repe-
tition of similar concepts; others may have rephrased these questions differently than we did.
Response bias was also likely since those who are interested in infant<6mmalnutrition are
more likely to respond to a survey on the topic than those who are not. This likely accounts for
our relatively low response rate to the questionnaire and is a problem common to all such
CHNRI-based assessments. We argue that it is not a serious challenge to the validity of the
study since those most interested and familiar with a topic are also in the best position to judge
how particular research questions might translate to subsequent practice or policy.
We note that governments and front-line fieldworkers in developing countries were not as
well represented (perhaps due to limited internet access to our online survey) as non-govern-
mental organisation (NGO) staff and academics based in industrialised countries. It is possible
that these under-represented groups may have answered our questions differently. However,
the latter group has particular interest, experience, and expertise in the subject, and so we still
believe that their responses are valid.
Unlike some other CHNRI papers, we did not apply weights to our seven judging criteria
(according to how the different issues are valued). Our approach is clearer to report, but may
not reflect values in practice.
Finally, we focused on management of SAM, an “end point” on a continuum of acute mal-
nutrition. Many of the research questions are applicable to moderate acute malnutrition since
the same challenges of how to identify cases and manage them effectively apply. Our focus on
SAM in this exercise prioritised those infants<6m with the most risk and also concurs with
the target group of the latest WHO guidance.
Potential Next Steps
Though often expensive, high-quality research is a vital investment towards future health and
social services that are effective and cost-effective. Many initiatives aim to improve research de-
sign, execution, and reporting so that questions are robustly answered [12,29,30]. More impor-
tant is to ask the “right” research questions in the first place. We are pleased that our process
has highlighted case definitions as the number-one priority for infants<6m. Agreement on
this point is vital for the validity and comparability of all other studies. Data already exists, so
one ambition is for our CHNRI to catalyse discussions and meetings that will rapidly reach
workable consensus on this. This and other prioritisation results are consistent with ten re-
search areas noted by WHO in 2013 (e.g., the need to better define infant<6m SAM; the need
to more clearly define therapeutic strategies) [11]. The added value of the CHNRI process and
framework is that it gives details and makes clear why certain questions matter and how they
might make an impact (e.g., some research questions may be easily answerable but may not
make much subsequent impact; others may be challenging (or expensive) to answer but have
great potential to improve future intervention effectiveness and sustainability). As well as over-
all ranking, CHRNI thereby exposes the strengths and weaknesses of numerous potential re-
search options. It is in this that we see other next steps:
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• For researchers: our list will support individuals and institutions considering or applying for
research funding related to infant<6m SAM. Current focus areas can be compared with
those recognised by a wider community. Improving alignment (or justifying differences) be-
tween the two will help make a powerful case for investment.
• For funders: our list can be used to help shape grant calls and decide which projects to
ultimately fund.
We emphasise that we do not see our list as final or immutable but as a starting point for ongo-
ing dialogue, development, and refinement of research options. As current top questions are
answered, others will take their place. Contexts will also change. What will always help, howev-
er, is having a framework to guide fair and rational discussions and decisions. Towards this, we
believe that the CHNRI approach has a key role to play.
Conclusions
The management of acute malnutrition in infants<6m (MAMI) is a critical area for child
health and nutrition; prioritising research is important for making the biggest advances as
quickly as possible. Our results suggest the need for a broad approach spanning basic epidemi-
ology, health policies and systems, and more specialist interventions. Fundamental questions,
such as how to define SAM in infants<6m, are most urgent. Other priorities include research
on how to integrate MAMI into existing programmes and practices; how to provide appropri-
ate breastfeeding support; and how to assess treatment coverage. The 2013 WHO SAM guide-
lines create an important stimulus to action. Our CHNRI builds on this by informing global
efforts and providing technical direction on an agreed-on and transparent operational research
agenda: maximising opportunities, avoiding duplication of effort and waste of resources, and
designing research that will most effectively inform policy change and front-line practice. All
ultimately lead to MAMI treatments with the biggest possible impact on infant<6mmortality,
morbidity, and nutrition.
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